Literature DB >> 31860397

Recombinant Adeno-Associated Virus Quality Control for Non-Clinical and Clinical Vectors: How an Unregulated Commercial Sector Can Compromise Development of New Gene Therapies.

Robert M Kotin1, J Fraser Wright2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31860397     DOI: 10.1089/hum.2019.29099.rmk

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  1 in total

1.  Gene therapy - are we ready now?

Authors:  Radoslaw Kaczmarek
Journal:  Haemophilia       Date:  2022-05       Impact factor: 4.263

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.